Literature DB >> 23407650

TIF1γ-overexpressing, highly progressive endometrial carcinoma in a patient with dermato-myositis positive for malignancy-associated anti-p155/140 autoantibody.

Akira Kasuya1, Yasuhito Hamaguchi, Manabu Fujimoto, Yoshiki Tokura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23407650     DOI： 10.2340/00015555-1550

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   4.437


× No keyword cloud information.
  8 in total

Review 1.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

2.  Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.

Authors:  Hanbo Yang; Qinglin Peng; Liguo Yin; Shanshan Li; Jingli Shi; Yamei Zhang; Xin Lu; Xiaoming Shu; Sigong Zhang; Guochun Wang
Journal:  Arthritis Res Ther       Date:  2017-11-25       Impact factor: 5.156

3.  Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study.

Authors:  Huaxia Yang; Zhuoran Yao; Xiaoxiang Zhou; Zhongxing Bing; Lei Cao; Zhili Cao; Shanqing Li; Xuan Zhang; Yan Zhao; Xiaofeng Zeng; Fengchun Zhang; Naixin Liang
Journal:  Ann Transl Med       Date:  2020-11

4.  Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis.

Authors:  Yu Nakanishi; Kakuhiro Yamaguchi; Yusuke Yoshida; Shinjiro Sakamoto; Yasushi Horimasu; Takeshi Masuda; Taku Nakashima; Shintarou Miyamoto; Hiroshi Iwamoto; Shintaro Hirata; Kazunori Fujitaka; Hironobu Hamada; Eiji Sugiyama; Noboru Hattori
Journal:  Intern Med       Date:  2020-06-23       Impact factor: 1.271

Review 5.  Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.

Authors:  Renske G Kamperman; Anneke J van der Kooi; Marianne de Visser; Eleonora Aronica; Joost Raaphorst
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

Review 6.  Bench to bedside review of myositis autoantibodies.

Authors:  Boaz Palterer; Gianfranco Vitiello; Alessia Carraresi; Maria Grazia Giudizi; Daniele Cammelli; Paola Parronchi
Journal:  Clin Mol Allergy       Date:  2018-03-07

Review 7.  Update on Malignancy in Myositis-Well-Established Association with Unmet Needs.

Authors:  Aleksandra H Opinc; Joanna S Makowska
Journal:  Biomolecules       Date:  2022-01-11

8.  Severe onset of inflammatory myositis in a child: think to paraneoplastic myositis.

Authors:  Simone Benvenuto; Giulia Gortani; Rossana Bussani; Federico Poropat; Flora Maria Murru; Marco Carrozzi; Alberto Tommasini; Andrea Taddio
Journal:  Ital J Pediatr       Date:  2021-07-01       Impact factor: 2.638
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.